Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1860 2
1881 1
1929 1
1930 1
1937 1
1939 1
1940 1
1946 2
1947 1
1948 7
1949 1
1950 3
1951 3
1952 9
1953 4
1954 6
1955 6
1957 5
1958 2
1959 3
1960 2
1961 2
1962 5
1963 5
1964 11
1965 8
1966 5
1967 13
1968 5
1969 5
1970 2
1971 12
1972 10
1973 10
1974 7
1975 18
1976 7
1977 3
1978 6
1979 3
1980 3
1981 5
1982 11
1983 10
1984 7
1985 20
1986 10
1987 16
1988 15
1989 18
1990 13
1991 26
1992 20
1993 17
1994 15
1995 16
1996 16
1997 21
1998 21
1999 21
2000 32
2001 41
2002 41
2003 35
2004 43
2005 31
2006 36
2007 31
2008 37
2009 32
2010 36
2011 38
2012 52
2013 47
2014 41
2015 45
2016 40
2017 56
2018 59
2019 65
2020 61
2021 70
2022 74
2023 59
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,500 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies.
Bowden SJ, Doulgeraki T, Bouras E, Markozannes G, Athanasiou A, Grout-Smith H, Kechagias KS, Ellis LB, Zuber V, Chadeau-Hyam M, Flanagan JM, Tsilidis KK, Kalliala I, Kyrgiou M. Bowden SJ, et al. Among authors: ellis lb. BMC Med. 2023 Jul 27;21(1):274. doi: 10.1186/s12916-023-02965-w. BMC Med. 2023. PMID: 37501128 Free PMC article. Review.
Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.
Lowentritt B, Pilon D, Khilfeh I, Rossi C, Muser E, Kinkead F, Waters D, Ellis L, Lefebvre P, Brown G. Lowentritt B, et al. Among authors: ellis l. Urol Oncol. 2023 May;41(5):253.e1-253.e9. doi: 10.1016/j.urolonc.2023.03.003. Epub 2023 Apr 13. Urol Oncol. 2023. PMID: 37061452 Free article.
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.
Qiu X, Boufaied N, Hallal T, Feit A, de Polo A, Luoma AM, Alahmadi W, Larocque J, Zadra G, Xie Y, Gu S, Tang Q, Zhang Y, Syamala S, Seo JH, Bell C, O'Connor E, Liu Y, Schaeffer EM, Jeffrey Karnes R, Weinmann S, Davicioni E, Morrissey C, Cejas P, Ellis L, Loda M, Wucherpfennig KW, Pomerantz MM, Spratt DE, Corey E, Freedman ML, Shirley Liu X, Brown M, Long HW, Labbé DP. Qiu X, et al. Among authors: ellis l. Nat Commun. 2022 May 13;13(1):2559. doi: 10.1038/s41467-022-30257-z. Nat Commun. 2022. PMID: 35562350 Free PMC article.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen CC, Wongvipat J, Ku SY, Gao D, Cao Z, Shah N, Adams EJ, Abida W, Watson PA, Prandi D, Huang CH, de Stanchina E, Lowe SW, Ellis L, Beltran H, Rubin MA, Goodrich DW, Demichelis F, Sawyers CL. Mu P, et al. Among authors: ellis l. Science. 2017 Jan 6;355(6320):84-88. doi: 10.1126/science.aah4307. Science. 2017. PMID: 28059768 Free PMC article.
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.
Morel KL, Sheahan AV, Burkhart DL, Baca SC, Boufaied N, Liu Y, Qiu X, Cañadas I, Roehle K, Heckler M, Calagua C, Ye H, Pantelidou C, Galbo P, Panja S, Mitrofanova A, Wilkinson S, Whitlock NC, Trostel SY, Hamid AA, Kibel AS, Barbie DA, Choudhury AD, Pomerantz MM, Sweeney CJ, Long HW, Einstein DJ, Shapiro GI, Dougan SK, Sowalsky AG, He HH, Freedman ML, Balk SP, Loda M, Labbé DP, Olson BM, Ellis L. Morel KL, et al. Among authors: ellis l. Nat Cancer. 2021 Apr;2(4):444-456. doi: 10.1038/s43018-021-00185-w. Epub 2021 Mar 22. Nat Cancer. 2021. PMID: 33899001 Free PMC article.
Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A retrospective cohort study.
Lowentritt B, Pilon D, Waters D, Rossi C, Muser E, Kurteva S, Shah A, Khilfeh I, Du S, Ellis L, Lefebvre P, Brown G. Lowentritt B, et al. Among authors: ellis l. Urol Oncol. 2023 May;41(5):252.e19-252.e27. doi: 10.1016/j.urolonc.2023.03.013. Epub 2023 Apr 19. Urol Oncol. 2023. PMID: 37080833 Free article.
1,500 results